Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA536263
Max Phase: Preclinical
Molecular Formula: C6H10Cl2N2
Molecular Weight: 108.14
Molecule Type: Small molecule
Associated Items:
ID: ALA536263
Max Phase: Preclinical
Molecular Formula: C6H10Cl2N2
Molecular Weight: 108.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.NCc1ccncc1
Standard InChI: InChI=1S/C6H8N2.2ClH/c7-5-6-1-3-8-4-2-6;;/h1-4H,5,7H2;2*1H
Standard InChI Key: VZTITPMLZPPLRB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 108.14 | Molecular Weight (Monoisotopic): 108.0687 | AlogP: 0.54 | #Rotatable Bonds: 1 |
Polar Surface Area: 38.91 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.06 | CX LogP: -0.12 | CX LogD: -1.77 |
Aromatic Rings: 1 | Heavy Atoms: 8 | QED Weighted: 0.57 | Np Likeness Score: -0.54 |
1. Bertini V, Buffoni F, Ignesti G, Picci N, Trombino S, Iemma F, Alfei S, Pocci M, Lucchesini F, De Munno A.. (2005) Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases., 48 (3): [PMID:15689151] [10.1021/jm0408316] |
Source(1):